Page last updated: 2024-11-03

rizatriptan and Astrocytoma

rizatriptan has been researched along with Astrocytoma in 1 studies

rizatriptan: structure given in first source; RN given refers to benzoate

Astrocytoma: Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baqi, Y1
Pillaiyar, T1
Abdelrahman, A1
Kaufmann, O1
Alshaibani, S1
Rafehi, M1
Ghasimi, S1
Akkari, R1
Ritter, K1
Simon, K1
Spinrath, A1
Kostenis, E1
Zhao, Q1
Köse, M1
Namasivayam, V1
Müller, CE1

Other Studies

1 other study available for rizatriptan and Astrocytoma

ArticleYear
3-(2-Carboxyethyl)indole-2-carboxylic Acid Derivatives: Structural Requirements and Properties of Potent Agonists of the Orphan G Protein-Coupled Receptor GPR17.
    Journal of medicinal chemistry, 2018, 09-27, Volume: 61, Issue:18

    Topics: Animals; Antineoplastic Agents; Astrocytoma; Calcium; Humans; Indoles; Models, Molecular; Molecular

2018